Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent D Stewart

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|March 14, 2007
Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitorsZhi-Fu Tao, Le Wang, Kent D Stewart, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitorsZhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.
Molecular Cancer Therapeutics|December 21, 2002
Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylaseKeith B Glaser, Junling Li, Mary E Aakre, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2011
Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinasesWilliam J McClellan, Yujia Dai, Cele Abad-Zapatero, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modelingYunsong Tong, Kent D Stewart, Sheela Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2006
Xanthine mimetics as potent dipeptidyl peptidase IV inhibitorsRavi Kurukulasuriya, Jeffrey J Rohde, Bruce G Szczepankiewicz, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2012
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitorsQingwei Zhang, Zhiren Xia, Michael J Mitten, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitorsZhiqin Ji, Yujia Dai, Cele Abad-Zapatero, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strainsChen Zhao, Hing L Sham, Minghua Sun, et al.
Journal of Medicinal Chemistry|June 19, 2008
7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitorsRobin R Frey, Michael L Curtin, Daniel H Albert, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|March 14, 2007
Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitorsZhi-Fu Tao, Le Wang, Kent D Stewart, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitorsZhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.
Molecular Cancer Therapeutics|December 21, 2002
Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylaseKeith B Glaser, Junling Li, Mary E Aakre, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2011
Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinasesWilliam J McClellan, Yujia Dai, Cele Abad-Zapatero, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modelingYunsong Tong, Kent D Stewart, Sheela Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2006
Xanthine mimetics as potent dipeptidyl peptidase IV inhibitorsRavi Kurukulasuriya, Jeffrey J Rohde, Bruce G Szczepankiewicz, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2012
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitorsQingwei Zhang, Zhiren Xia, Michael J Mitten, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitorsZhiqin Ji, Yujia Dai, Cele Abad-Zapatero, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strainsChen Zhao, Hing L Sham, Minghua Sun, et al.
Journal of Medicinal Chemistry|June 19, 2008
7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitorsRobin R Frey, Michael L Curtin, Daniel H Albert, et al.
Pageof 7